These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8230738)

  • 1. [The dose-response study of sparfloxacin against skin and soft tissue structure infections in the field of surgery].
    Nakayama I; Yamaji E; Kawamura H; Kawaguchi H; Akieda Y; Suzuki T; Watanabe T; Itokawa K
    Jpn J Antibiot; 1993 Aug; 46(8):706-25. PubMed ID: 8230738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and bacteriological study of sparfloxacin on bacterial prostatitis].
    Suzuki K; Horiba M; Naide Y; Shinoda M; Hibi H
    Hinyokika Kiyo; 1992 Jan; 38(1):121-8. PubMed ID: 1312292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The studies on clinical efficacy of Tomiron in the surgical patients: skin and soft tissue infection].
    Kobayashi N; Yamaoka Y; Yamauchi A; Honda K; Shimahara Y; Mori K; Tanaka K; Ozawa K; Okamoto M; Wakabayashi H
    Nihon Geka Hokan; 1989 Nov; 58(6):493-507. PubMed ID: 2519185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical study of sparfloxacin, a new quinolone derivative, on urinary tract infection].
    Suzuki K; Horiba M; Naide Y; Shinoda M; Hibi H; Okishio N; Yanagioka M; Nagakubo I
    Hinyokika Kiyo; 1991 Dec; 37(12):1749-57. PubMed ID: 1664649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Experimental and clinical studies of temafloxacin in the field of obstetrics and gynecology].
    Matsuda S; Shimizu T; Cho N; Okada H
    Jpn J Antibiot; 1993 Jun; 46(6):492-504. PubMed ID: 8395608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on sparfloxacin (SPFX) in the treatment of mycoplasmal pneumonia and penetration of SPFX to the pneumonic lesion].
    Hayashi Y; Ito G; Takeyama S
    Kansenshogaku Zasshi; 1998 Jan; 72(1):54-9. PubMed ID: 9503785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies of lomefloxacin in biliary tract infections].
    Ono Y; Kunii O
    Jpn J Antibiot; 1989 Apr; 42(4):1017-24. PubMed ID: 2769934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparfloxacin versus ciprofloxacin for the treatment of community-acquired, complicated skin and skin-structure infections.
    Lipsky BA; Miller B; Schwartz R; Henry DC; Nolan T; McCabe A; Magner DJ; Talbot GH
    Clin Ther; 1999 Apr; 21(4):675-90. PubMed ID: 10363733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous fleroxacin versus ceftazidime for lower respiratory tract and skin and soft-tissue infections.
    Huston MJ; Lentino JR
    Clin Ther; 1992; 14(4):595-602. PubMed ID: 1525793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical evaluation of biapenem in various infectious diseases].
    Hara K; Baba S; Matsumoto F; Ooishi M; Kawada Y; Arata J; Shinagawa N; Sasaki J; Hayasi K; Sugihara T; Matsuda S
    Jpn J Antibiot; 1999 Nov; 52(11):629-60. PubMed ID: 10659441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A clinical study on S6472, sustained release preparation of cefaclor, dermatological area].
    Kawanami T; Shibata A; Hanawa S; Morishima T
    Jpn J Antibiot; 1990 Sep; 43(9):1621-8. PubMed ID: 2262967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical studies on lenampicillin in the therapy of skin and soft tissue infections].
    Fujita K; Takahashi H; Takeshima M; Nonami E; Horie N; Kubota Y; Katsumata M; Kukita A; Watanabe S; Miura Y
    Jpn J Antibiot; 1985 Jun; 38(6):1423-67. PubMed ID: 4046172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antimycobacterial activities of a new quinolone, sparfloxacin].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Oct; 66(10):643-9. PubMed ID: 1660089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic antimicrobial therapy in skin and skin structure infections: comparison of temafloxacin and ciprofloxacin.
    Parish LC; Jungkind DL
    Am J Med; 1991 Dec; 91(6A):115S-119S. PubMed ID: 1662880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical investigation of a long-acting amoxicillin preparation in patients with skin and soft-tissue infections].
    Nakayama I; Akieda Y; Watanabe T; Suzuki T; Itokawa K
    Jpn J Antibiot; 1983 May; 36(5):1137-63. PubMed ID: 6620561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical efficacy of T-3262, a new quinolone compound, on urinary tract infection in 1988].
    Suzuki K; Nagata Y
    Hinyokika Kiyo; 1989 Apr; 35(4):717-26. PubMed ID: 2735274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical study on fleroxacin in surgical infections].
    Yura J; Shinagawa N; Ishikawa S; Mashita K; Kinoshita H; Morimoto K; Sakai K; Mizuno A; Ishikawa M; Suzuki T
    Jpn J Antibiot; 1991 Jun; 44(6):614-24. PubMed ID: 1909762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dose finding study of sparfloxacin in single-dose therapy for female acute uncomplicated cystitis].
    Hirose T; Yoshiaki K; Yokoo A; Umehara T; Miyake M; Takatsuka K; Sato T; Miyamoto S; Tanaka N; Miyao N
    Kansenshogaku Zasshi; 1992 Oct; 66(10):1462-72. PubMed ID: 1338088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.